<?xml version="1.0" encoding="UTF-8"?>
<p>In coordination with ongoing efforts to optimize and broaden access to current treatment regimens, expansion of research and development (R&amp;D) of new tropical disease drugs is critical, and in alignment with SDG Target 3.B [
 <xref rid="B4-tropicalmed-04-00053" ref-type="bibr">4</xref>]. Despite substantial global interest in and commitment to tropical disease drug discovery and development, there remain significant unmet needs for new medications that address concerns associated with existing therapies, such as emergence of drug resistance [
 <xref rid="B3-tropicalmed-04-00053" ref-type="bibr">3</xref>,
 <xref rid="B7-tropicalmed-04-00053" ref-type="bibr">7</xref>,
 <xref rid="B8-tropicalmed-04-00053" ref-type="bibr">8</xref>]; lack of efficacy against infectious agents at all stages of their lifecycles [
 <xref rid="B8-tropicalmed-04-00053" ref-type="bibr">8</xref>]; lack of direct antimicrobial activity (i.e., only supportive care is available) [
 <xref rid="B9-tropicalmed-04-00053" ref-type="bibr">9</xref>]; and toxicity [
 <xref rid="B10-tropicalmed-04-00053" ref-type="bibr">10</xref>].
</p>
